21 C.F.R. § 864.7300

Current through September 30, 2024
Section 864.7300 - Fibrin monomer paracoagulation test
(a)Identification. A fibrin monomer paracoagulation test is a device used to detect fibrin monomer in the diagnosis of disseminated intravascular coagulation (nonlocalized clotting within a blood vessel) or in the differential diagnosis between disseminated intravascular coagulation and primary fibrinolysis (dissolution of the fibrin in a blood clot).
(b)Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9 . The special control for this device is FDA's "In Vitro Diagnostic Fibrin Monomer Paracoagulation Test." See § 864.1(d) for information on obtaining this document.

21 C.F.R. §864.7300

45 FR 60614, Sept. 12, 1980, as amended at 52 FR 17733, May 11, 1987; 65 FR 17144, Mar. 31, 2000, 84 FR 71799, Dec. 30, 2019
84 FR 71799, 12/30/2019